rabbit monoclonal eno1 (Abcam)
Structured Review

Rabbit Monoclonal Eno1, supplied by Abcam, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit monoclonal eno1/product/Abcam
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Helicase-like transcription factor (HLTF) -deleted CDX/TME model of colorectal cancer increased transcription of oxidative phosphorylation genes and diverted glycolysis to boost S-glutathionylation in lymphatic intravascular metastatic niches"
Article Title: Helicase-like transcription factor (HLTF) -deleted CDX/TME model of colorectal cancer increased transcription of oxidative phosphorylation genes and diverted glycolysis to boost S-glutathionylation in lymphatic intravascular metastatic niches
Journal: PLOS ONE
doi: 10.1371/journal.pone.0291023

Figure Legend Snippet: Source, application and concentration of antibodies.
Techniques Used: Concentration Assay, Recombinant, Plasmid Preparation

Figure Legend Snippet: Summary of site-specific S-glutathionylation identified by 2D-DIGE MALDI-TOF/TOF mass spectrometry. Pr-SSG in HLTF -/- CDX/TME.
Techniques Used: Mass Spectrometry
eno1 rabbit monoclonal abcam wb (Danaher Inc)


Structured Review
Eno1 Rabbit Monoclonal Abcam Wb, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/eno1 rabbit monoclonal abcam wb/product/Danaher Inc
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
rabbit anti eno1 monoclonal antibody (Abcam)
Structured Review

Rabbit Anti Eno1 Monoclonal Antibody, supplied by Abcam, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti eno1 monoclonal antibody/product/Abcam
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Diagnostic value of α-enolase expression and serum α-enolase autoantibody levels in lung cancer"
Article Title: Diagnostic value of α-enolase expression and serum α-enolase autoantibody levels in lung cancer
Journal: Jornal Brasileiro de Pneumologia
doi: 10.1590/S1806-37562016000000241

Figure Legend Snippet: Photomicrographs showing α-enolase (ENO1) expression in lung tissue samples (immunohistochemistry using the streptavidin-peroxidase staining method). Positive signs are visualized as yellow or brownish yellow granules. In A and B, adenocarcinoma tissue samples showing positive ENO1 expression (magnification, ×400 and ×100, respectively). In C and D, squamous cell carcinoma tissue samples showing positive ENO1 expression (magnification, ×400 and ×100, respectively). In E and F, pulmonary inflammatory pseudotumor tissue samples showing negative ENO1 expression (magnification, ×400 and ×100, respectively).
Techniques Used: Expressing, Immunohistochemistry, Staining

Figure Legend Snippet: ROC curve showing the sensitivity and specificity of serum α-enolase antibody levels for the diagnosis of lung cancer.
Techniques Used:
rabbit monoclonal anti eno1 (Abcam)
Structured Review

Rabbit Monoclonal Anti Eno1, supplied by Abcam, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit monoclonal anti eno1/product/Abcam
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling"
Article Title: Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling
Journal: iScience
doi: 10.1016/j.isci.2021.103607

Figure Legend Snippet: Proteo-transcriptomic integration confirms HIF signaling and glycolysis as unique features of the male EC phenotype Proteo-transcriptomic analysis in HC (n = 9 ), EC (n = 9 ), and VP (n = 9 ). (A) Upset plot describing the number of features detected by each of the sparse partial least squares models. (B) Schematic representation of the derivation of EC-specific proteins. (C) PCA plot representing sample clustering with respect to EC-specific proteins. The first two principal components capturing maximum of variance were used. Data ellipses were drawn at the level of 0.9. (D) Heatmap visualizing quantile normalized and Z-scaled expression pattern of EC-specific proteins. Column annotation represents the cohorts and the different groups used for pairwise comparison. Proteins are hierarchically clustered based on Euclidean distance. (E) Functional analysis results of proteins belonging to cluster 1 in (D). Size of the bubble and the color gradient are relative to number of features in each pathway and adjusted p value of the enrichment test, respectively. (F) Functional analysis results of the proteins belonging to cluster 2 in (D). The bubble size and color gradient are relative to number of features in each pathway and adjusted p value of the enrichment test, respectively. (G) Schematic representation of the proteins belonging to pathways in (F). Circular nodes in red represents upregulated proteins in EC, in relation to HC, and gray color denotes non-significant expression levels. (H) Western blot analysis of HIF target genes identified in (G) for male HC (n = 9 ), and EC (n = 9 ). (I) Violin plots representing relative protein quantification of HIF-1α, ENO1, and ENO3 normalized to β-Actin from (H) using unpaired t test (significance level, p < 0.05) represented with violin plot with mean. See also
Techniques Used: Expressing, Functional Assay, Western Blot

Figure Legend Snippet:
Techniques Used: Software
anti eno1 rabbit monoclonal antibody (Abcam)
Structured Review
Anti Eno1 Rabbit Monoclonal Antibody, supplied by Abcam, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti eno1 rabbit monoclonal antibody/product/Abcam
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
monoclonal rabbit anti eno1 (Abcam)
Structured Review
Monoclonal Rabbit Anti Eno1, supplied by Abcam, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal rabbit anti eno1/product/Abcam
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
rabbit anti eno1 monoclonal antibodies (Abcam)
Structured Review

Rabbit Anti Eno1 Monoclonal Antibodies, supplied by Abcam, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti eno1 monoclonal antibodies/product/Abcam
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "α-enolase is highly expressed in liver cancer and promotes cancer cell invasion and metastasis"
Article Title: α-enolase is highly expressed in liver cancer and promotes cancer cell invasion and metastasis
Journal: Oncology Letters
doi: 10.3892/ol.2020.12003

Figure Legend Snippet: ENO1 expression in liver cancer tissue and peripheral blood of patients with liver cancer. (A) ENO1 expression in liver cancer tissues (×100). (B) ENO1 was not expressed in benign liver lesions (×100). (C) Serum anti-ENO1 antibody levels in patients with liver cancer were higher than those in patients with benign liver lesions and healthy controls. (D) ENO1 expression in liver cancer tissues (×400). (E) ENO1 was not expressed in benign liver lesion (×400). (F) Receiver operating characteristic curve analysis for liver cancer diagnosis using anti-ENO1 antibody levels. The AUC was 0.741, the sensitivity was 64.3% and the specificity was 85.5%. The red dot represents the cut-off value. **P<0.01; ****P<0.0001 ENO1, α-enolase; AUC, area under the curve.
Techniques Used: Expressing

Figure Legend Snippet: ENO1 expression in pathological tissues.
Techniques Used: Expressing
![Comparison of the serum anti-ENO1 antibody levels among the three groups ... Comparison of the serum anti-ENO1 antibody levels among the three groups of participants [P50 (P25-P75)].](https://pub-med-central-html-table-images-cdn.bioz.com/pub_med_central_ids_ending_with_1668/pmc07471668/pmc07471668__tII-ol-0-0-12003__rabbit_ascii32_anti_ascii32_eno1_ascii32_monoclonal_ascii32_antibodies__abcam.jpg)
Figure Legend Snippet: Comparison of the serum anti-ENO1 antibody levels among the three groups of participants [P50 (P25-P75)].
Techniques Used:

Figure Legend Snippet: Validation of the siRNA interference effect on ENO1 expression in liver cancer cells. (A) RT-qPCR validation of the effect of siRNA interference on ENO1 expression in HepG2 cells. The results showed that the relative expression levels of the ENO1 gene in the si-1 and si-2 groups were lower than those in the control group. (B) RT-qPCR validation of the effect of siRNA interference on ENO1 expression in Huh7 cells. The results showed that the relative expression levels of the ENO1 gene in the si-1 and si-2 groups were lower than those in the control group. (C) Western blot validation of the effect of siRNA interference on ENO1 expression in HepG2 cells. The results showed that the relative expression levels of the ENO1 protein in HepG2 cells in the si-1 and si-2 groups were significantly lower than those in the control group. (D) Western blot validation of the effect of siRNA interference on ENO1 expression in Huh7 cells. The results showed that the relative expression levels of the ENO1 protein in Huh7 cells in the si-1 and si-2 groups were significantly lower than those in the control group. **P<0.01; ****P<0.0001. siRNA, small interfering RNA; ENO1, α-enolase; si-1, siRNA interference group 1; si-2, siRNA interference group 2; RT-qPCR, reverse transcription-quantitative PCR.
Techniques Used: Expressing, Quantitative RT-PCR, Western Blot, Small Interfering RNA, Real-time Polymerase Chain Reaction

Figure Legend Snippet: Effect of ENO1 siRNA on liver cancer cell proliferation. (A) HepG2 and (B) Huh7 cell proliferation was suppressed after ENO1 siRNA treatment. Results show that 72 h after transfection in the si-1 and si-2 groups, ENO1 siRNA treatment resulted in proliferation inhibition in HepG2 and Huh7 cells. In HepG2 cells, the differences in cell proliferation between the NC and the siRNA-treated groups were statistically significant (P<0.05 vs. si-2 group and P<0.01 vs. si-1 group). Cell proliferation in Huh7 cells was also significantly different. *P<0.05; **P<0.01. ENO1, α-enolase; siRNA, small interfering RNA; si-1, siRNA interference group 1; si-2, siRNA interference group 2; OD, optical density; NC, negative control.
Techniques Used: Transfection, Inhibition, Small Interfering RNA, Negative Control

Figure Legend Snippet: Effect of ENO1 siRNA on the migration ability of liver cancer cells. (A) Compared with that of the NC group, HepG2 cell migration after ENO1 siRNA treatment became slower in the si-1 and si-2 groups, and the difference was statistically significant at 48 h after treatment. (B) Gap size was measured using ImageJ software and the ratio of gap size after ENO1 siRNA treatment in HepG2 cells was calculated based on the size of the wound at 0 h. (C) Compared with that of the NC group, Huh7 cell migration after ENO1 siRNA treatment became slower in the si-1 and si-2 groups, and the difference was statistically significant at 48 h after treatment. (D) Gap size was measured with the ImageJ software and the ratio of gap size after ENO1 siRNA treatment in Huh7 cell was calculated based on the size of the wound at 0 h. *P<0.05; **P<0.01. ENO1, α-enolase; siRNA, small interfering RNA; NC, negative control; si-1, siRNA interference group 1; si-2, siRNA interference group 2.
Techniques Used: Migration, Software, Small Interfering RNA, Negative Control

Figure Legend Snippet: Effect of ENO1 siRNA on the invasion and migration abilities of liver cancer cells. Compared with the NC group, the in vitro invasion and migration abilities of (A) HepG2 and (B) Huh7 cells after ENO1 siRNA treatment decreased in the si-1 and si-2 groups, and the differences were statistically significant. Numbers of (C) HepG2 and (D) Huh7 cells were measured with the ImageJ software after ENO1 siRNA treatment. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001. ENO1, α-enolase; siRNA, small interfering RNA; NC, negative control; si-1, siRNA interference group 1; si-2, siRNA interference group 2.
Techniques Used: Migration, In Vitro, Software, Small Interfering RNA, Negative Control
rabbit anti eno1 monoclonal antibody (Abcam)
Structured Review

Rabbit Anti Eno1 Monoclonal Antibody, supplied by Abcam, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti eno1 monoclonal antibody/product/Abcam
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Cardiac troponin I autoantibody induces myocardial dysfunction by PTEN signaling activation"
Article Title: Cardiac troponin I autoantibody induces myocardial dysfunction by PTEN signaling activation
Journal: EBioMedicine
doi: 10.1016/j.ebiom.2019.08.045

Figure Legend Snippet: cTnIAAb binds to α-enolase (ENO1) in myocardial cell membrane. a. The concentrated purified protein from BCG823 cell lysates through cTnImAb1-dextran affinity chromatography was subjected to SDS-PAGE followed by Coomassie blue staining, which revealed one single band. b. The purified protein from BCG823 cell lysates specifically bound to ENO1 mAb, but could not bind to cTnImAb1 again. Left : Western blotting showing that the purified protein from BCG823 cell lysates through cTnImAb1-dextran affinity chromatography could not interact with cTnImAb1 again. Middle : Western blotting showing that the purified protein from BCG823 cell lysates through cTnImAb1-dextran affinity chromatography could specifically bind to ENO1 mAb (51 KDa). Right : Western blotting showing that the non-reduced protein lysates from mouse cardiomyocytes interacted with cTnImAb1 at both 28 kDa and 51 kDa, while the reduced protein lysates interacted with cTnImAb1 only at 28 kDa. c. Immunoblot analysis showed that cTnImAb1 and anti-ENO1 pAb bound to the immunoprecipitation-purified endogenous dimeric ENO1 from cardiomyocytes. Far Left : Mouse cTnImAb1 strongly interacted with the unreduced ENO1 dimer (line 6, ~98 kDa) immunoprecipitated by rabbit ENO1 mAb155102, while it weakly interacted with the reduced endogenous ENO1 (line 3, ~47 kDa). Mouse cTnImAb1 interacted with myocardial cTnI (lines 2 and 5, ~28 kDa) as well as the unreduced input protein sample (line 2, ~98 kDa). Left : Mouse ENO1 pAb strongly interacted with the unreduced ENO1 dimer (line 6, ~98 kDa) immunoprecipitated by rabbit ENO1 mAb155102, while it weakly interacted with the reduced endogenous ENO1 (line 3, ~47 kDa). Mouse ENO1 pAb interacted with myocardial ENOI (lines 2 and 5, ~47 kDa) as well as the unreduced input protein sample (line 2, ~98 kDa). Right : Rabbit ENO1 mAb155955 interacted with ENO1 in the input protein sample (lines 2 and 5) as well as the immunoprecipitated endogenous ENO1 by rabbit ENO1 mAb155102 (lines 3 and 6). Rabbit ENO1 mAb155102 also bound to anti rabbit IgG (lines 4 and 7). Far Right : Mouse actin mAb interacted with the actin in the input protein sample (lines 2 and 5). All images are representative of at least 3 independent iterations. d. Identification of FLAG-tagged recombinant wild-type and C389A, C357A, C339A, C119A ENO1 protein expressed in 293 T cells. e. The reaction of recombinant ENO1 protein and 4 point-mutated ENO1 proteins with cTnImAb1 and Anti-ENO1 (non-reducing sample) respectively. Results shown are representative immunoblot analysis of three independent co-immunoprecipitation analysis. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Techniques Used: Purification, Affinity Chromatography, SDS Page, Staining, Western Blot, Immunoprecipitation, Recombinant

Figure Legend Snippet: cTnImAb1 upregulates the expression of ENO1 and induces cardiomyocyte apoptosis, while silencing ENO1 attenuates cTnImAb1–induced cardiomyocyte apoptosis. a & b. cTnImAb1 treatment (0, 25, 50, or 100 μg/ml) for 48 h induced cardiomyocyte apoptosis in a dose-dependent manner as revealed by flow cytometry. a , representative images. b , quantification of 3 independent experiments. * p = .000 (ANOVA analysis). c. cTnImAb1 treatment for 48 h at indicated doses increased Bax, cleaved Caspase3, and caspase8/p18 expression, and decreased Bcl2 expression in a dose-dependent manner as revealed by immunoblot analysis. β-actin served as a loading control. Shown are representative images of 3 independent experiments. d&e. cTnImAb1 treatment (50 μg/ml) for indicated times induced cardiomyocyte apoptosis in a time-dependent manner as revealed by flow cytometry. d , representative images. e , quantification of 3 independent experiments, * p = .000 (ANOVA analysis). f. cTnImAb1 treatment (50 μg/ml) for indicated times increased Bax, cleaved Caspase3, and caspase8/p18 expression, and decreased Bcl2 expression in a dose-dependent manner as revealed by immunoblot analysis. β-actin served as a loading control. Shown are representative images of 3 independent experiments. g-i. cTnImAb1 treatment (50 μg/ml) for 48 h increased ENO1 expression of primary cultured cardiomyocytes ( i ) compared with mouse IgG ( g ) and cTnTmAb ( h ) treatments as revealed by immunohistochemistry. Bar = 50 μm. j&k. cTnImAb1 treatment (50 μg/ml) for 48 h increased ENO1 expression compared with mouse IgG treatments as revealed by immunoblot analysis. β-actin served as a loading control. Shown are representative images ( j ) and quantification by ImageJ-mediated densitometry analysis ( k ) of 3 independent experiments. * p = .000 ( t -test). l&m. Silencing ENO1 attenuated cTnImAb1 (50 μg/ml)-induced cardiomyocyte apoptosis compared with mock-siRNA group. l , Annexin V-PI staining was used for flow cytometric analysis. Representative images are shown. m , Quantification of Annexin-V/PI staining from 3 independent experiments. 24 h * p = .008, 48 h * p = .000 ( t -test). n&o. RNAi-mediated silencing of Eno1 in primary cultured cardiomyocytes significantly reduced the cTnImAb1 (50 μg/ml)-induced cardiomyocyte apoptosis by increasing Bax expression and decreasing Bcl2 expression compared with mock-siRNA group. Representative immunoblot images are shown in n . ImageJ-based quantification of ENO1 (*ENO1-siRNA p = .000, Mock-siRNA p = .000), Bax (*ENO1-siRNA p = .000, Mock-siRNA p = .000), and Bcl2 (*ENO1-siRNA p = .003, Mock-siRNA p = .020) protein expression is shown in o. (ANOVA analysis).
Techniques Used: Expressing, Flow Cytometry, Western Blot, Cell Culture, Immunohistochemistry, Staining

Figure Legend Snippet: cTnImAb1 treatment increases ENO1 expression followed by activation of PTEN and suppression of Akt signaling in mouse hearts. a. Heat map from PathScan® Akt Signaling Antibody Array kit analysis showing changes in 16 phosphorylated proteins. b & c. Statistical analysis of heat map data in a and volcano plot showing that cTnImAb1 treatment significantly increased PTEN Ser380 phosphorylation in the mouse heart. 1. PTEN Ser380, *p = .023, ( t -test). 2. GSK-3b Ser9, * p = .038, ( t -test). 3. PTEN Ser380, * p = .031 ( t -test). d&e. Immunoblot analysis showed that cTnImAb1 treatment significantly increased ENO1 expression and PTEN Ser380 phosphorylation but suppressed Akt Thr308 phosphorylation. β-actin served as a loading control. e is the statistical analysis of d . ENO1 * p = .002, pPTEN/PTEN/Actin, * p = .003, pAkt/Akt/Actin, * p = .003. (ANOVA analysis). f-h. cTnImAb1 treatment (50 μg/ml) induced changes in ENO1 expression and phosphorylation of PTEN Ser380 and Akt Thr308 at different time points in cultured cardiomyoyctes. cTnImAb1 increased the p-Ser380-PTEN/total PTEN ratio at 8 h but decreased the pThr308-AKT/total Akt ratio at 8–12 h. Mouse IgG treatment did not alter pSer380 PTEN but significantly increased the pThr308-Akt/total Akt ratio at 24–36 h. f shows representative blot images of three independent experiments. g and h represent ImageJ-based densitometry analysis of relative changes in p-Ser380-PTEN/total PTEN ratio ( G, 8 h * p = .020, 12 h * p = .024, t -test) and pThr308-AKT/total Akt ( H , 12 h * p = .018, 24 h * p = .001, 36 h * p = .001, t -test). i-l. Knockdown of ENO1 significantly suppressed cTnImAb1–induced alteration in PTEN/Akt signaling. Cultured cardiomyocytes were transfected with siRNA targeting Eno1 and then subjected to cTnImAb1 treatment (50 μg/ml) for 4–48 h as indicated. Mock-siRNA was used as a control. Depletion of Eno1 suppressed the p-PTEN Ser380/total PTEN ratio and increased the pAkt-Thr308/total Akt ratio at 4, 8, and 12 h, respectively. i shows representative blot images of three independent experiments. j represents ImageJ-based densitometry analysis of relative changes in ENO1 protein levels ( J ,48 h * p = .000, t -test). k and l represent ImageJ-based densitometry analysis of relative changes in p-Ser380-PTEN/total PTEN ratio ( k, 48 h * p = .000, t -test) and pThr308-AKT/total Akt ( l, 6 h * p = .000, 12 h * p = .000, t -test).
Techniques Used: Expressing, Activation Assay, Ab Array, Western Blot, Cell Culture, Transfection

Figure Legend Snippet: Graphical mechanism summary: Human cTnIAAb interacts with ENO1 present in the myocardial membrane and induces apoptosis of cultured cardiomyocytes. Human cTnIAAb can trigger cardiomyocyte apoptosis via binding membrane ENO1, increasing ENO1 expression, promoting phosphorylation of PTEN Ser380, and suppressing Akt activity in the mouse model of cTnImAb-induced myocardial injury. This induces the pro-apoptotic Bax and suppresses the anti-apoptotic Bcl2 expression resulting in cardiomyocyte apoptosis.
Techniques Used: Cell Culture, Binding Assay, Expressing, Activity Assay
rabbit monoclonal anti eno1 antibody (Abcam)
Structured Review

Rabbit Monoclonal Anti Eno1 Antibody, supplied by Abcam, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit monoclonal anti eno1 antibody/product/Abcam
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "p300-Mediated Lysine 2-Hydroxyisobutyrylation Regulates Glycolysis"
Article Title: p300-Mediated Lysine 2-Hydroxyisobutyrylation Regulates Glycolysis
Journal: Molecular cell
doi: 10.1016/j.molcel.2018.04.011

Figure Legend Snippet: (A) Both PFK and ENO1 enzymes display reduced activities in p300 KO HCT116 cells. WT and p300 KO HCT116 cells were cultured in complete medium. The activities of PFK and ENO1 from total cell lysates were measured using colorimetric assay kits (n=3, *p<0.05, values are expressed as mean ±SEM).
Techniques Used: Cell Culture, Colorimetric Assay

Figure Legend Snippet: Key Resources Table
Techniques Used: Recombinant, shRNA, Clone Assay, Synthesized, Activity Assay, Mutagenesis, Mass Spectrometry, Western Blot, Sequencing, Software
rabbit anti eno1 monoclonal antibody (Abcam)
Structured Review
Rabbit Anti Eno1 Monoclonal Antibody, supplied by Abcam, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti eno1 monoclonal antibody/product/Abcam
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99